Company: STAA
Filing Date: 2025-09-19
Form Type: DEFA14A
Source: 0001193125-25-209066
Chunk: 1

Company: STAAR SURGICAL CO
Filing Date: 2025-09-19
Form: DEFA14A
Chunk 1
---
123,456,789,012.00000 |
| STAAR SURGICAL COMPANY      |     | 123,456,789,012.00000 |
| STAAR SURGICAL COMPANY      |     | 123,456,789,012.00000 |
| STAAR SURGICAL COMPANY      |     | 123,456,789,012.00000 |
| STAAR SURGICAL COMPANY      |     | 123,456,789,012.00000 |
| STAAR SURGICAL CO COMMON    |     | 123,456,789,012.00000 |

| View documents:                  
 Notice of Meeting and Proxy      
 Statement | Shareholder Letter | |

| © 2025 Broadridge Financial Solutions Inc.                                                                                                                  
 P.O. Box 1310, Brentwood, NY 11717 ProxyVote and Broadridge are                                                                                             
 trademarks of Broadridge Financial Solutions Inc. CUSIP is a registered trademark of the American Bankers Association. All other registered marks belong to 
 their respective owners.   Email Settings | Terms and Conditions | Privacy Statement                                                                        |

-2-

Additional Information About the Merger and Where to Find It

This communication relates to the proposed transaction involving STAAR. In connection with the proposed transaction, STAAR has filed relevant materials with
the U.S. Securities and Exchange Commission (the “SEC”), including STAAR’s definitive proxy statement on Schedule 14A (the “Proxy Statement”), on September 16, 2025. The Proxy Statement was first sent to STAAR
stockholders on September 16, 2025. This communication is not a substitute for the Proxy Statement or any other document that STAAR may file with the SEC or send to its stockholders in connection with the proposed transaction. BEFORE MAKING ANY
VOTING DECISION, STOCKHOLDERS OF STAAR ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC, INCLUDING THE PROXY STATEMENT, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS THERETO, IN CONNECTION WITH THE PROPOSED TRANSACTION WHEN THEY
BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain the documents (when available) free of charge at the SEC’s website, www.sec.gov, or by
visiting STAAR’s investor relations website,